查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1787233

下一代定序文库製备的全球市场

Next-generation Sequencing Library Preparation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 220 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

至2030年，全球次世代定序文库製备市场规模将达41亿美元

2024年，全球新一代定序文库製备市场规模估计为19亿美元，预计到2030年将达到41亿美元，在2024-2030年的分析期间内，复合年增长率为13.4%。标靶基因组定序是本报告分析的细分市场之一，预计其复合年增长率为10.4%，到分析期结束时达到14亿美元。全基因组定序细分市场在分析期间的复合年增长率估计为15.8%。

美国市场规模估计为 5.035 亿美元，中国市场预计复合年增长率为 12.8%

美国新一代定序文库製备市场规模预计在2024年达到5.035亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到6.382亿美元，在分析期间（2024-2030年）的复合年增长率为12.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为11.9%和11.8%。在欧洲，预计德国的复合年增长率为10.1%。

全球下一代定序文库製备市场—主要趋势与驱动因素摘要

下一代定序文库製备如何推动基因组研究？

新一代定序 (NGS)样品製备是基因组分析的关键步骤，研究人员利用此技术将 DNA 和 RNA 样本转化为适合高通量定序的格式。製备过程包括片段化、接头连接、扩增和品管，以确保定序的准确性和高效性。 NGS 技术彻底改变了遗传学，使其能够在精准医疗、肿瘤学、感染疾病研究和农业基因组学等各种应用中，以更快、更经济的方式分析基因组、转录组和表观基因。 NGS 在临床诊断中的应用日益广泛，这推动了对更精简、更易于自动化且可扩展的文库製备试剂套件的需求，这些试剂盒可提高效率和可重复性。此外，单细胞和长读长定序的进展正在突破基因组分析的界限，需要改进复杂样本的文库製备方法。随着研究人员努力提高定序的准确性、灵敏度和通量，文库製备技术不断发展，并在基因组学领域的发展中发挥关键作用。

哪些挑战影响了NGS库製备技术的采用？

儘管NGS库製备市场具有变革潜力，但它仍面临着许多挑战，影响其可近性、效率和成本效益。其中一个主要问题是传统文库製备方法的劳动密集特性，需要熟练的技术人员、昂贵的试剂和大量的样本处理。样本品质和製备效率的差异可能导致定序错误和数据不可靠，因此需要强有力的品管措施。另一个主要挑战是文库製备试剂套件的高成本，这对于规模较小的研究和临床实验室来说可能成本过高。此外，处理各种样本类型（包括低输入和劣化的DNA）的复杂性需要高度专业化的方案，这推动了对客製化解决方案的需求。临床实验室必须遵守基于NGS的诊断的严格合规性要求，因此监管挑战和标准化问题进一步阻碍了临床应用。克服这些挑战需要在自动化、试剂化学和生物资讯解决方案方面不断创新，以使NGS库製备更有效率、更具成本效益，并可扩展至广泛的应用领域。

技术创新如何推动NGS库製备的未来？

技术进步显着提高了NGS库製备的效率和准确性，解决了样本处理和序列品质的关键挑战。其中最具影响力的创新之一是样本製备工作流程的自动化，它减少了手动操作时间，最大限度地减少了人为错误，并提高了试样处理通量。机器人液体处理系统和微流体平台正在简化製备过程，使临床和研究实验室更容易进行高通量定序。基于转座酶的文库製备方法的开发，例如 Illumina 的 Nextera 技术，简化了 DNA 片段化和接头插入，减少了製备时间和试剂成本。此外，单管和直接 RNA 定序方法消除了复杂的工作流程，提高了转录组学研究的效率。分子条码和唯一分子标识符 (UMI) 的进步可透过减少 PCR 偏差和检测低频变异来提高定序准确性。人工智慧和机器学习在生物资讯学中的整合也透过预测最佳试剂条件和改进数据解释来优化文库製备通讯协定。随着这些创新的不断发展， NGS库製备市场将有望提高效率、扩充性和临床应用。

推动NGS库製备市场成长的因素有哪些？

下一代定序文库製备市场的成长受到多种因素的驱动，包括个人化医疗需求的不断增长、NGS在疾病研究中的应用不断扩大以及自动化和试剂化学技术的进步。基于NGS的诊断在肿瘤学、感染疾病和罕见遗传疾病中的日益普及，推动了对更有效率、更具成本效益的文库製备解决方案的需求。单细胞定序的兴起也促进了市场的成长，因为研究人员需要专门的文库製备方法来对单一细胞进行灵敏的分析。此外，农业基因组学、微生物组研究和合成生物学的扩展进一步推动了市场需求，因为这些领域利用高通量测序进行基因组分析。临床NGS应用的标准化和监管核准的推动力也在塑造市场，製造商正在开发符合严格诊断要求的兼容文库製备试剂套件。对生物资讯学和云端基础的测序平台的投资正在增强数据管理和可访问性，促进NGS广泛应用于各种研究和临床应用。随着定序技术的进步降低成本并提高准确性， NGS库製备市场预计将经历持续成长，从而彻底改变基因组研究和精准医疗。

部分

定序类型（标靶基因组定序、全基因组定序、全外EXOME定序、其他定序类型）、产品类型（建库试剂及耗材、建库设备）、应用领域（药物研发及生物标记发现、疾病诊断、感染疾病诊断、生殖医学诊断、传染病

受访公司范例

  • Agilent Technologies, Inc.
  • Alida Biosciences, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company（BD）
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Claret Bioscience LLC
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • Hamilton Company
  • Illumina, Inc.
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Swift Biosciences Inc.
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP32336

Global Next-generation Sequencing Library Preparation Market to Reach US$4.1 Billion by 2030

The global market for Next-generation Sequencing Library Preparation estimated at US$1.9 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. Targeted Genome Sequencing, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Whole Genome Sequencing segment is estimated at 15.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$503.5 Million While China is Forecast to Grow at 12.8% CAGR

The Next-generation Sequencing Library Preparation market in the U.S. is estimated at US$503.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$638.2 Million by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.9% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.

Global Next-Generation Sequencing Library Preparation Market - Key Trends & Drivers Summarized

How Is Next-Generation Sequencing Library Preparation Advancing Genomic Research?

Next-generation sequencing (NGS) library preparation is a critical step in genomic analysis, enabling researchers to convert DNA and RNA samples into formats suitable for high-throughput sequencing. The preparation process involves fragmentation, adapter ligation, amplification, and quality control, ensuring accurate and efficient sequencing. NGS technology has revolutionized genetics, allowing for faster and more cost-effective analysis of genomes, transcriptomes, and epigenomes across various applications, including precision medicine, oncology, infectious disease research, and agricultural genomics. The increasing adoption of NGS in clinical diagnostics is driving demand for more streamlined, automation-friendly, and scalable library preparation kits that enhance efficiency and reproducibility. Additionally, advancements in single-cell sequencing and long-read sequencing are pushing the boundaries of genome analysis, necessitating improved library preparation methods tailored for complex samples. As researchers strive for higher sequencing accuracy, sensitivity, and throughput, library preparation technologies continue to evolve, playing a crucial role in advancing the field of genomics.

What Challenges Are Affecting the Adoption of NGS Library Preparation Technologies?

Despite its transformative potential, the NGS library preparation market faces several challenges that impact accessibility, efficiency, and cost-effectiveness. One of the primary concerns is the labor-intensive nature of traditional library preparation methods, which require skilled technicians, expensive reagents, and extensive sample handling. Variability in sample quality and preparation efficiency can lead to sequencing errors and reduced data reliability, necessitating robust quality control measures. Another major challenge is the high cost of library preparation kits, which can be prohibitive for smaller research institutions and clinical laboratories. Additionally, the complexity of handling diverse sample types, including low-input and degraded DNA, requires highly specialized protocols, increasing the need for customized solutions. Regulatory challenges and standardization issues further hinder clinical adoption, as laboratories must adhere to stringent compliance requirements for NGS-based diagnostics. Overcoming these challenges will require continued innovation in automation, reagent chemistry, and bioinformatics solutions to make NGS library preparation more efficient, cost-effective, and scalable for a wider range of applications.

How Are Innovations Driving the Future of NGS Library Preparation?

Technological advancements are significantly improving the efficiency and accuracy of NGS library preparation, addressing key challenges in sample processing and sequencing quality. One of the most impactful innovations is the automation of library preparation workflows, reducing hands-on time, minimizing human error, and increasing sample throughput. Robotic liquid handling systems and microfluidic platforms are streamlining the preparation process, making high-throughput sequencing more accessible to clinical and research laboratories. The development of transposase-based library preparation methods, such as Illumina’s Nextera technology, is simplifying DNA fragmentation and adapter insertion, reducing preparation time and reagent costs. Additionally, single-tube and direct RNA sequencing approaches are eliminating the need for complex workflows, improving efficiency in transcriptomics studies. Advances in molecular barcoding and unique molecular identifiers (UMIs) are enhancing sequencing accuracy by reducing PCR bias and detecting low-frequency variants. The integration of AI and machine learning in bioinformatics is also optimizing library preparation protocols by predicting optimal reagent conditions and improving data interpretation. As these innovations continue to evolve, the NGS library preparation market is poised for greater efficiency, scalability, and clinical adoption.

What Is Driving the Growth of the NGS Library Preparation Market?

The growth in the next-generation sequencing library preparation market is driven by several factors, including increasing demand for personalized medicine, expanding applications of NGS in disease research, and technological advancements in automation and reagent chemistry. The growing adoption of NGS-based diagnostics in oncology, infectious diseases, and rare genetic disorders is fueling demand for more efficient and cost-effective library preparation solutions. The rise of single-cell sequencing is also contributing to market growth, as researchers require specialized library preparation methods to analyze individual cells with high sensitivity. Additionally, the expansion of agricultural genomics, microbiome studies, and synthetic biology is further driving market demand, as these fields rely on high-throughput sequencing for genomic analysis. The push for standardization and regulatory approvals for clinical NGS applications is also shaping market trends, with manufacturers developing compliant library preparation kits that meet stringent diagnostic requirements. Investments in bioinformatics and cloud-based sequencing platforms are enhancing data management and accessibility, making NGS more widely available for diverse research and clinical applications. As advancements in sequencing technologies continue to lower costs and improve accuracy, the NGS library preparation market is expected to witness sustained growth, revolutionizing genomic research and precision medicine.

SCOPE OF STUDY:

The report analyzes the Next-generation Sequencing Library Preparation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Other Sequencing Types); Product Type (Library Preparation Reagents & Consumables, Library Preparation Instruments); Application (Drug & Biomarker Discovery Application, Disease Diagnostics Application, Cancer Diagnostics Application, Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications); End-Use (Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • Agilent Technologies, Inc.
  • Alida Biosciences, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Claret Bioscience LLC
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • Hamilton Company
  • Illumina, Inc.
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Swift Biosciences Inc.
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Next-generation Sequencing Library Preparation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Precision Medicine Initiatives Throws the Spotlight on Customized NGS Library Preparation Solutions
    • Rapid Growth of Clinical Diagnostics Strengthens Business Case for Automation in Library Preparation Workflows
    • Increasing Focus on Genomic Surveillance Accelerates Demand for High-Throughput NGS Library Prep Kits
    • Rising Investments in Cancer Genomics Propels Growth of Targeted Sequencing Library Preparation Products
    • Expansion of Population Genomics Programs Expands Addressable Market Opportunity for Large-Scale Library Prep Platforms
    • Adoption of AI and Machine Learning in Genomic Data Analysis Spurs Demand for Standardized, High-Quality Library Prep Methods
    • Growing Use of Liquid Biopsy Technologies Drives Adoption of Ultra-Sensitive Library Preparation Protocols
    • Regulatory Push for Validated and Reproducible Clinical Assays Strengthens Business Case for Commercial NGS Library Kits
    • Integration of Automation and Robotics in Lab Workflows Drives Efficiency and Reduces Human Error in Library Preparation
    • Increasing Demand for Decentralized Testing Models Spurs Development of Point-of-Care Compatible Library Prep Technologies
    • Rising Demand for Epigenetic and Transcriptomic Studies Expands Scope for Specialized Library Preparation Solutions
    • Advancements in Long-Read Sequencing Technologies Drives Innovation in Compatible Library Preparation Reagents
    • Continuous Decline in Sequencing Costs Sustains Growth Momentum Across Research and Clinical Applications
    • Strategic Collaborations Between Pharma and Genomics Firms Fuel Adoption of Scalable NGS Library Preparation Platforms
    • Expansion of Biobanking and Genomic Data Repositories Generates Long-Term Demand for Reliable Library Prep Protocols
    • Transition to Cloud-Based Genomics Workflows Spurs Demand for Seamlessly Integratable Library Prep Solutions
    • Emphasis on Quality Control and Standardization Across Labs Strengthens Need for Pre-Validated Library Prep Kits
    • Accelerating Adoption of NGS in Agriculture and Microbiome Research Opens New Market Avenues for Library Preparation Products
    • Government Funding Initiatives and Genomics-Focused National Programs Drive Regional Market Penetration and Adoption
    • Intensifying Competitive Landscape Spurs Innovation in Fast, Cost-Effective, and Scalable Library Preparation Technologies
    • Emergence of Single-Cell Sequencing Drives Demand for Ultra-Low Input and Specialized Library Prep Workflows
    • Growing Importance of Data Privacy and Compliance Creates Challenges in Adoption of Cloud-Linked NGS Prep Systems
    • Movement Toward Personalized Wellness and Preventive Healthcare Expands Market Opportunity for Consumer-Directed Library Prep Solutions
    • Increasing Academia-Industry Collaborations Propels Development of Customizable and Niche Library Preparation Technologies
    • Shift Toward Multiplexed and Multi-Omic Sequencing Accelerates Innovation in Versatile Library Prep Protocols
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Next-generation Sequencing Library Preparation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Next-generation Sequencing Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Targeted Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Targeted Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Sequencing Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Sequencing Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Reproductive Health Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Reproductive Health Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Infectious Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Disease Diagnostic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Other Disease Diagnostic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Drug & Biomarker Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Drug & Biomarker Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Cancer Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Cancer Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Academic & Research Institutions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Academic & Research Institutions End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Library Preparation Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Library Preparation Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Library Preparation Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Library Preparation Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 36: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • JAPAN
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • CHINA
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 60: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • EUROPE
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • FRANCE
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 78: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • GERMANY
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • ITALY
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • UNITED KINGDOM
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 102: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030

IV. COMPETITION